{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:37:06Z","timestamp":1784227026642,"version":"3.55.0"},"reference-count":44,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"State of S\u00e3o Paulo Research Foundation","award":["2023\/03608-1"],"award-info":[{"award-number":["2023\/03608-1"]}]},{"name":"State of S\u00e3o Paulo Research Foundation","award":["001"],"award-info":[{"award-number":["001"]}]},{"name":"Coordination for the Improvement of Higher Education Personnel","award":["2023\/03608-1"],"award-info":[{"award-number":["2023\/03608-1"]}]},{"name":"Coordination for the Improvement of Higher Education Personnel","award":["001"],"award-info":[{"award-number":["001"]}]},{"name":"UFABC Multiuser Central Facilities","award":["2023\/03608-1"],"award-info":[{"award-number":["2023\/03608-1"]}]},{"name":"UFABC Multiuser Central Facilities","award":["001"],"award-info":[{"award-number":["001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology International"],"abstract":"<jats:p>Background\/Objectives: Antipsychotic medicines are used to treat several psychological disorders and some symptoms caused by dementia and schizophrenia. Haloperidol (Hal) is a typical antipsychotic usually used to treat psychosis; however, its use causes motor or extrapyramidal symptoms (EPS) such as catalepsy. Hal blocks the function of presynaptic D2 receptors on cholinergic interneurons, leading to the release of acetylcholine (ACh), which is hydrolyzed by the enzyme acetylcholinesterase (AChE). Methods: This study was designed to investigate the Hal-inhibitory effects on AChE activity in regions representative of the cholinergic system of mice and potential associations between cataleptic effects generated by Hal using therapeutic doses and their inhibitory effects on AChE. Results: The distribution of the AChE activity in the different regions of the brain followed the order striatum &gt; hippocampus &gt; (prefrontal cortex\/hypothalamus\/ cerebellum) &gt; brainstem &gt; septo-hippocampal system. In ex vivo assays, Hal inhibited AChE activity obtained from homogenate tissue of the striatum, hippocampus, and septo-hippocampal system in a concentration-dependent manner. The inhibitory concentration of 50% of enzyme activity (IC50) indicated that the septo-hippocampal system required a higher concentration of Hal (IC50 = 202.5 \u00b5mol\u00b7L\u22121) to inhibit AChE activity compared to the striatum (IC50 = 162.5 \u00b5mol\u00b7L\u22121) and hippocampus (IC50 = 145 \u00b5mol\u00b7L\u22121). In in vivo assays, male Swiss mice treated with concentrations of Hal higher than 0.1 mg\u00b7kg\u22121 induced cataleptic effects. Positive correlations with Spearman\u2019s correlation were observed only between the lack of cataleptic effect and the decreased AChE activity of the hippocampus in the mice treated with 0.01 mg\u00b7kg\u22121 of Hal but not in the striatum and septo-hippocampal system. Conclusions: Our results suggest that Hal could increase cholinergic effects via AChE inhibition, in addition to its dopamine antagonist effect, as an alternative approach to the treatment of behavioral disturbances associated with dementia.<\/jats:p>","DOI":"10.3390\/neurolint16060125","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T09:30:18Z","timestamp":1733391018000},"page":"1731-1741","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Haloperidol-Induced Catalepsy and Its Correlations with Acetylcholinesterase Activity in Different Brain Structures of Mice"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1585-7066","authenticated-orcid":false,"given":"Brenda Rufino da","family":"Silva","sequence":"first","affiliation":[{"name":"Natural and Humanities Sciences Center (CCNH), Experimental Morphophysiology Laboratory, Federal University of ABC (UFABC), S\u00e3o Bernardo do Campo 09606-070, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce Maria Ferreira Alexandre","family":"Lima","sequence":"additional","affiliation":[{"name":"Natural and Humanities Sciences Center (CCNH), Experimental Morphophysiology Laboratory, Federal University of ABC (UFABC), S\u00e3o Bernardo do Campo 09606-070, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela Bermudez","family":"Echeverry","sequence":"additional","affiliation":[{"name":"Center for Mathematics, Computation and Cognition (CMCC), Federal University of ABC (UFABC), S\u00e3o Bernardo do Campo 09606-070, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4519-8930","authenticated-orcid":false,"given":"Carlos","family":"Alberto-Silva","sequence":"additional","affiliation":[{"name":"Natural and Humanities Sciences Center (CCNH), Experimental Morphophysiology Laboratory, Federal University of ABC (UFABC), S\u00e3o Bernardo do Campo 09606-070, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11910-020-01074-y","article-title":"Psychosis in Alzheimer\u2019s Disease","volume":"20","author":"Ballard","year":"2020","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Podsiedlik, M., Markowicz-Piasecka, M., and Sikora, J. (2022). The Influence of Selected Antipsychotic Drugs on Biochemical Aspects of Alzheimer\u2019s Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23094621"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"113507","DOI":"10.1016\/j.bbr.2021.113507","article-title":"Schizophrenia: Antipsychotics and drug development","volume":"414","author":"Remington","year":"2021","journal-title":"Behav. Brain Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21249532","article-title":"Mechanism of Action of Atypical Antipsychotic Drugs in Mood Disorders","volume":"21","author":"Grinchii","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/FBP.0000000000000406","article-title":"Cross-tolerance between nitric oxide synthase inhibition and atypical antipsychotics modify nicotinamide-adenine-dinucleotide phosphate-diaphorase activity in mouse lateral striatum","volume":"30","author":"Prieto","year":"2019","journal-title":"Behav. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0010-440X(99)90082-2","article-title":"A history of antipsychotic drug development","volume":"40","author":"Shen","year":"1999","journal-title":"Compr. Psychiatry"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1345\/aph.1H241","article-title":"Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients","volume":"40","author":"Lacasse","year":"2006","journal-title":"Ann. Pharmacother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jamda.2007.08.007","article-title":"Atypical antipsychotics for the treatment of delirious elders","volume":"9","author":"Ozbolt","year":"2008","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2217\/pgs.16.5","article-title":"Possible biomarkers modulating haloperidol efficacy and\/or tolerability","volume":"17","author":"Porcelli","year":"2016","journal-title":"Pharmacogenomics"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"De la Casa, L.G., Cintado, M.A., Gonz\u00e1lez-Tirado, G., and C\u00e1rcel, L. (2023). Conditioned catalepsy vs. Increase in locomotor activity induced by haloperidol. Neurosci. Lett., 802.","DOI":"10.1016\/j.neulet.2023.137174"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1111\/ejn.15222","article-title":"Haloperidol-induced catalepsy as an animal model for parkinsonism: A systematic review of experimental studies","volume":"53","author":"Waku","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuron.2016.06.014","article-title":"Parkinsonism Driven by Antipsychotics Originates from Dopaminergic Control of Striatal Cholinergic Interneurons","volume":"91","author":"Kharkwal","year":"2016","journal-title":"Neuron"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Prasasty, V., Radifar, M., and Istyastono, E. (2018). Natural Peptides in Drug Discovery Targeting Acetylcholinesterase. Molecules, 23.","DOI":"10.3390\/molecules23092344"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/35067589","article-title":"Acetylcholinesterase--new roles for an old actor","volume":"2","author":"Soreq","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bbr.2010.02.025","article-title":"Localisation of pre- and postsynaptic cholinergic markers in the human brain","volume":"221","author":"Wevers","year":"2011","journal-title":"Behav. Brain Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer\u2019s disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000500227","article-title":"Inhibition of Recombinant Human Acetylcholinesterase Activity by Antipsychotics","volume":"104","author":"Obara","year":"2019","journal-title":"Pharmacology"},{"key":"ref_18","first-page":"576","article-title":"Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells","volume":"260","author":"Bolden","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2147\/NDT.S34433","article-title":"Profile of blonanserin for the treatment of schizophrenia","volume":"9","author":"Tenjin","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0024-3205(00)00911-5","article-title":"Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds","volume":"68","author":"Richelson","year":"2000","journal-title":"Life Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11010-013-1615-9","article-title":"Evaluation of acetylcholinesterase and adenosine deaminase activities in brain and erythrocytes and proinflammatory cytokine levels in rats submitted to neonatal hypoxia-ischemia model","volume":"378","author":"Pimentel","year":"2013","journal-title":"Mol. Cell Biochem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1385\/0-89603-612-X:237","article-title":"Biochemical Measurement of Cholinesterase Activity","volume":"22","author":"Padilla","year":"2003","journal-title":"Neurodegener. Methods Protoc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-2999(98)00391-4","article-title":"Olanzapine-induced Fos expression in the rat forebrain; cross-tolerance with haloperidol and clozapine","volume":"353","author":"Sebens","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/sj.npp.1300940","article-title":"Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties","volume":"31","author":"Bardin","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00213-007-0834-8","article-title":"Intracerebroventricular administration of nitric oxide-sensitive guanylyl cyclase inhibitors induces catalepsy in mice","volume":"194","author":"Echeverry","year":"2007","journal-title":"Psychopharmacology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s002130050003","article-title":"Sub-chronic inhibition of nitric-oxide synthesis modifies haloperidol-induced catalepsy and the number of NADPH-diaphorase neurons in mice","volume":"147","year":"2000","journal-title":"Psychopharmacology"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Prieto, S.G., Almeida, M.C., Silva, J.C.S., Del-Bel, E., and Echeverry, M.B. (2023). Extrapyramidal Side Effects with Chronic Atypical Antipsychotic Can Be Predicted by Labeling Pattern of FosB and phosphoThr34-DARPP-32 in Nucleus Accumbens. Biomedicines, 11.","DOI":"10.3390\/biomedicines11102677"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2169\/internalmedicine.39.863","article-title":"Parkinsonism onset in a patient concurrently using tiapride and donepezil","volume":"39","author":"Arai","year":"2000","journal-title":"Intern. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1176\/ajp.155.10.1458a","article-title":"Extrapyramidal side effects in a patient treated with risperidone plus donepezil","volume":"155","author":"Magnuson","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1345\/aph.17355","article-title":"Possible association between donepezil and worsening Parkinson\u2019s disease","volume":"32","author":"Bourke","year":"1998","journal-title":"Ann. Pharmacother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF00439268","article-title":"Cholinergic-dopaminergic interactions in experimental catalepsy","volume":"81","author":"Klemm","year":"1983","journal-title":"Psychopharmacology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0006-3223(88)90275-2","article-title":"Haloperidol alters rat CNS cholinergic system: Enzymatic and morphological analyses","volume":"24","author":"Mahadik","year":"1988","journal-title":"Biol. Psychiatry"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-023-00614-7","article-title":"Targeting a vulnerable septum-hippocampus cholinergic circuit in a critical time window ameliorates tau-impaired memory consolidation","volume":"18","author":"Wu","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1046\/j.1432-1327.1999.00693.x","article-title":"Structural roles of acetylcholinesterase variants in biology and pathology","volume":"264","author":"Grisaru","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/hipo.20235","article-title":"Restoring theta-like rhythmicity in rats restores initial learning in the Morris water maze","volume":"16","author":"McNaughton","year":"2006","journal-title":"Hippocampus"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1016\/j.celrep.2018.11.053","article-title":"Dopamine Cells Differentially Regulate Striatal Cholinergic Transmission across Regions through Corelease of Dopamine and Glutamate","volume":"25","author":"Cai","year":"2018","journal-title":"Cell Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1471-4159.1976.tb01592.x","article-title":"Effects of chronic treatment with neuroleptics on striatal acetylcholine concentration","volume":"27","author":"Sethy","year":"1976","journal-title":"J. Neurochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cbpc.2009.01.008","article-title":"Typical and atypical antipsychotics alter acetylcholinesterase activity and ACHE expression in zebrafish (Danio rerio) brain","volume":"150","author":"Seibt","year":"2009","journal-title":"Comp. Biochem. Physiol. C Toxicol. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00428402","article-title":"Evidence for a cholinergic role in haloperidol-induced catalepsy","volume":"85","author":"Klemm","year":"1985","journal-title":"Psychopharmacology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.biopsych.2006.03.080","article-title":"Acetylcholinesterase modulates stress-induced motor responses through catalytic and noncatalytic properties","volume":"60","author":"Sklan","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/neu.2021.33","article-title":"The effects of galangin in prepulse inhibition test and experimental schizophrenia models","volume":"34","author":"Kaygisiz","year":"2022","journal-title":"Acta Neuropsychiatr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic. Clin. Pharm."}],"container-title":["Neurology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2035-8377\/16\/6\/125\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:47:36Z","timestamp":1760114856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2035-8377\/16\/6\/125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["neurolint16060125"],"URL":"https:\/\/doi.org\/10.3390\/neurolint16060125","relation":{},"ISSN":["2035-8377"],"issn-type":[{"value":"2035-8377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]}}}